![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Malignant Lymphoma |
|
Free Subscription
1 Am J Clin Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Malignant Lymphoma is free of charge.
CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell
myeloma.
Am J Clin Pathol. 2026;165:aqag078.
PubMed
Abstract available
B cell receptor signaling promotes endogenous retrovirus-associated
lymphomagenesis in T-cell-deficient B6-Ly5.1 mice.
Biochem Biophys Res Commun. 2026;828:154139.
PubMed
Abstract available
The role of allogeneic stem cell transplantation in peripheral T-cell lymphoma.
Bone Marrow Transplant. 2026 Jun 29. doi: 10.1038/s41409-026-02962.
PubMed
Abstract available
Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation
radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the
prospective RESTART protocol.
Br J Haematol. 2026 Jul 3. doi: 10.1111/bjh.70653.
PubMed
Abstract available
The Endothelial Activation and Stress Index (EASIX) at diagnosis is associated
with survival in primary central nervous system lymphoma.
Br J Haematol. 2026 Jul 2. doi: 10.1111/bjh.70641.
PubMed
Abstract available
Hyperlactataemia in lymphoma-associated haemophagocytic lymphohistiocytosis:
Linked to monocytic glycolysis and adverse prognosis.
Br J Haematol. 2026 Jul 1. doi: 10.1111/bjh.70637.
PubMed
Abstract available
Clinical outcomes of the chemo-free approach in relapsed/refractory follicular
lymphoma: A network meta-analysis.
Br J Haematol. 2026 Jul 1. doi: 10.1111/bjh.70649.
PubMed
Abstract available
Effects of chronic lymphocytic leukaemia (CLL)-directed therapy on diffuse large
B-cell lymphoma (DLBCL) type Richter transformation compared to de novo DLBCL in
a nationwide cohort.
Br J Haematol. 2026 Jul 1. doi: 10.1111/bjh.70651.
PubMed
Abstract available
Nivolumab and chemotherapy combination approved for previously untreated Hodgkin
lymphoma.
Cancer. 2026;132:e70455.
PubMed
Epstein-Barr Virus MicroRNAs as Key Regulators of Lymphoma Pathogenesis: Immune
Evasion Mechanisms and Therapeutic Opportunities.
Eur J Haematol. 2026 Jun 28. doi: 10.1111/ejh.70249.
PubMed
Abstract available
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated
with durable responses without increased toxicity in patients with B-cell
non-Hodgkin lymphoma.
Haematologica. 2026 Jul 2. doi: 10.3324/haematol.2025.300321.
PubMed
Abstract available
Female sex is associated with superior outcomes in patients treated with
CD19-directed CAR T-cell therapy for large B-cell lymphoma.
Haematologica. 2026 Jul 2. doi: 10.3324/haematol.2026.300993.
PubMed
Abstract available
Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed /
refractory classic Hodgkin lymphoma.
Haematologica. 2026 Jul 2. doi: 10.3324/haematol.2026.300899.
PubMed
Abstract available
Impact of heme on the therapeutic efficacy of anti-CD20 antibodies.
J Biol Chem. 2026;302:111485.
PubMed
Abstract available
Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle
Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine
Kinase Inhibitor.
J Clin Oncol. 2026 Jul 1:JCO2600550. doi: 10.1200/JCO-26-00550.
PubMed
Abstract available
Re: Cardiovascular disease risk after radiotherapy and anthracycline-based
chemotherapy for diffuse large B-cell lymphoma.
J Natl Cancer Inst. 2026 Jun 3:djag165. doi: 10.1093.
PubMed
PD-L2 is associated with lineage-related transcriptional programs distinct from
PD-L1 in primary mediastinal large B-cell lymphoma.
Leukemia. 2026 Jul 1. doi: 10.1038/s41375-026-03016.
PubMed
Abstract available
A targeted circulating tumor DNA landscape of copy number aberrations in large
B-cell lymphomas.
Leukemia. 2026;40:1381-1391.
PubMed
Abstract available
LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding
ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling.
Oncogene. 2026 Jun 29. doi: 10.1038/s41388-026-03868.
PubMed
Abstract available
Thank you for your interest in scientific medicine.